Reslizumab subcutaneous (SC) vs placeboHealth‐related quality of life (AQLQ)Scale from: 1‐7 (higher is better) · people with asthma1 finding from 1 reviewAnti‐IL‐5 therapies for asthma 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 464 participantsHigh
Reslizumab subcutaneous (SC) vs placeboHealth‐related quality of life (ACQ) Scale from: 0 to 6 (lower is better) · people with asthma1 finding from 1 reviewAnti‐IL‐5 therapies for asthma 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 464 participantsHigh
Reslizumab subcutaneous (SC) vs placeboSGRQ Total SGRQ (Total) Score. Scale from: 0 to 100. Lower score indicates better quality of life. · people with asthma1 finding from 1 reviewAnti‐IL‐5 therapies for asthma 2022 · Cochrane Headline outcomes onlyno estimate extracted1 study · 464 participantsHigh